Contraception claims by medication for opioid use disorder prescription status among insured women with opioid use disorder, United States, 2018.

ABSTRACT:

Objective(s)

To understand how contraception method use differed between women prescribed and not prescribed medications for opioid use disorder (MOUD) among commercially-insured and Medicaid-insured women.

Study design

IBM Watson Health MarketScan Commercial Claims and Encounters database and the Multi-State Medicaid database were used to calculate the (1) crude prevalence, and (2) adjusted odds ratios (adjusted for demographic characteristics) of using long-acting reversible or short-acting hormonal contraception methods or female sterilization compared with none of these methods (no method) in 2018 by MOUD status among women with OUD, aged 20 to 49 years, with continuous health insurance coverage through commercial insurance or Medicaid for ≥6 years. Claims data was used

SUBMITTER: Goyal S 

PROVIDER: S-EPMC9722562 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature